Steve R. Ommen, M.D.

My primary research interest lies in the assessment of hypertrophic cardiomyopathy (HCM). We continue to assess and improve upon treatment strategies for patients with symptoms related to HCM. Sudden cardiac death is an important and devastating complication of HCM requiring our attention to understand risk stratification and appropriate use of implantable defibrillators.

Working in collaboration with other Mayo investigators, we are examining the relationships between the variation in HCM genotypes and clinical presentation. We have developed the world's largest clinical database of HCM patients and are systematically studying the genetic underpinnings of this disease. Interpreting the genetic discoveries into clinical implications and practice is the main objective.

I am also involved in non-invasive cardiac hemodynamics and the assessment of left ventricular diastolic function using echocardiographic techniques.